News and Events

Meet NEOMED-LABS team at the World Vaccine Congress in Washington from April 14 to 17!

April 4, 2019

We will present during the Influenza and Respiratory Vaccines session and will welcome you at our booth # 422 to discuss immunology assay development and clinical sample testing. We look forward to seeing you there!

Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers

March 28, 2019

LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service provider specialized in assay development and clinical laboratory testing for vaccines and soluble large molecules, announced today the appointment of Tim McGrath to the role of Chief Operating Officer. In his role, he will contribute … Continued

Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS

November 19, 2018

WELLESLEY, MA, LAVAL, QC, and SEATTLE, WA, November 19, 2018 – Ampersand Capital Partners announced today that it has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company NEOMED-LABS. This merger brings together two leading bioanalytical CROs with unrivaled credentials in immunology and particular expertise in assay development, custom biomarker validation, … Continued

Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute

September 4, 2018

LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute. NEOMED-LABS is a leading provider of clinical immunology laboratory services … Continued